The epididymis plays an essential role in male fertility, and disruption of epididymal function can lead to obstructive azoospermia. Formation and function of the epididymis is androgen-dependent. The androgen receptor (AR) is expressed in both the stromal and epithelial compartments of the epididymis, and androgen action mediated via stromal cells is vital for its normal development and function. However the impact of epithelial specific AR-dependent signaling in the epididymis remains underexplored. To address this, we used conditional gene-targeting in mice to selectively ablate AR from the caput epididymal epithelium, and characterized the resulting phenotype at multiple postnatal ages. Caput epithelium androgen receptor knock-out mice have normal serum testosterone concentrations at day (d) 21 and d100, but do not develop an epididymal initial segment. The remaining caput epithelium displays a significant decrease in epithelial cell height from d11 and lumen diameter from d21 and disruption of the smooth muscle layer of the caput epididymis at d100. From d21, caput epithelium androgen receptor knock-out mice accumulate cell debris, proteinaceous material, and, at later ages, spermatozoa in their efferent ducts, which prevents normal passage of spermatozoa from the testis into the cauda epididymis resulting in infertility when tested at d100. This efferent duct obstruction leads to fluid back-pressure and disruption of the seminiferous epithelium of the adult testis. We conclude that epithelial AR signaling is essential for postnatal development and function of the epididymal epithelium and that disruption of this signaling can contribute to obstructive azoospermia.
T he epididymis connects the efferent ducts to the vas deferens and provides a specialized environment supporting maturation and storage of spermatozoa. Failure of spermatozoa to transit normally through the epididymis can cause obstructive azoospermia (1) , and changes in the epididymal microenvironment can inhibit the function of spermatozoa in the female reproductive tract (2) ; both are common causes of male infertility.
Formation and function of the epididymis is androgendependent (3) . Rodent epididymides develop from the mesonephric tubules and proximal Wolffian ducts (WD) (4) . Although WDs develop in both sexes, they have a dimorphic fate. In males, the production of testosterone by fetal Leydig cells (LC) during the male programming window stabilizes and rescues the WD (5), whereas they regress in females due to the lack of androgens. Androgen action is mediated by the androgen receptor (AR), a single copy gene expressed on the X-chromosome (6) . Genetic mutations in AR (7, 8) or treatment with AR antagonists during the male programming window (9) results in regression of the WD and an absence of the epididymis in adult males. In mice, AR mRNA can be detected in the mesonephric stroma from embryonic day (e) 12.5 (10) . WD stabilization occurs at e15.5 (11) , before expression of AR in the WD epithelium, which is first detected at e19.5 (12) , suggesting that AR signaling within the stro-mal compartment is sufficient for the initial stabilization of the WD in fetal life. Expression of AR persists in the postnatal stroma and epithelium of the epididymis (13) .
At postnatal ages, acute withdrawal of androgens after orchidectomy results in apoptosis of epididymal epithelial principal cells (14, 15) and dedifferentiation of the caput epididymal epithelium to a 'precursor' state (16) , demonstrating that androgens are important for maintenance of epithelial cell identity. However, whether this impact of testosterone withdrawal is due to direct action on the epithelial cells or indirect action via the stromal cells remains unclear, as both cell types express AR. In vitro tissue recombination experiments with seminal vesicle stroma and epithelium have suggested that epithelial AR is required for expression of specific secretory proteins (17) . Because the seminal vesicles also develop from the WD, it is possible that epithelial AR has a similar role in the epididymis; however, specific role(s) for epithelial AR signaling within the epididymis remain relatively unknown.
Conditional gene-targeting has provided novel insights into the impact of AR signaling on multiple cell types within the male reproductive system (18 -23) . In the current study we have used this approach to ablate AR from epididymal caput epithelium to establish the role of epithelial AR in the development and function of the caput epididymis.
Materials and Methods

Targeted ablation of AR from epididymides using FoxG1-Cre mice
Mice in which the AR has been selectively ablated from the caput epididymis epithelial cells were generated using Cre/loxP technology. Male congenic 129Svev mice carrying a knock-in of Cre Recombinase at one copy of the FoxG1 locus (24) were mated to C57BL/6J female mice homozygous for a floxed AR (18) . The ϩ/Cre, AR flox /y male offspring from these matings were termed caput epithelium androgen receptor knock-out (CEARKO), whereas the ϩ/ϩ, AR flox /y littermates were used as controls, termed 'control'. A Cre-inducible YFP reporter line used to document the expression of the FoxG1-Cre transgene was generated by mating FoxG1-Cre males to female mice homozygous for a YFP transgene inserted into the Rosa26 locus (25) . The ϩ/Cre, ϩ /R26EYFPR male offspring from these matings expressed YFP in cells that expressed the FoxG1-Cre transgene and were termed 'FoxG1YFP.' ϩ/ϩ, ϩ/R26EYFPR littermates from these matings were termed 'ControlYFP.' ϩ/Cre mice were also generated by mating FoxG1-Cre stud males to C57BL/6J females to confirm that expression of Cre alone did not induce a phenotype. Sex and genotype ratios were all identified at the expected Mendelian ratios. All mice were bred under standard conditions of care and use under licensed approval from the UK Home Office (60/3544, Saunders).
PCR genotyping of mice
Stud male FoxG1-Cre mice were identified by genotyping from ear or tail DNA for the presence of Cre using PCR primers as follows: 5Ј, GATCGCTGCCAGGATATACG; 3Ј: AGGC-CAGGTATCTCTGACCA, with Biomix Red PCR kit (Bioline, UK). Females homozygous for AR flox were identified using primers for AR exon 2 as previously reported (22) . All male offspring of these matings were genotyped for the presence of Cre using the primers detailed above; all male offspring were hemizygous for X-linked AR flox .
Recovery of reproductive tissues
Male mice were culled at postnatal day (d) 2, 11, 16, 21, 35, and 100 by inhalation of carbon dioxide and subsequent cervical dislocation. Body weight and anogenital distance were measured, and mice were examined for any gross abnormalities of the reproductive system. Testes and epididymides were removed and weighed. Tissues were either snap-frozen for subsequent RNA analysis or fixed in Bouin's fixative (Clin-Tech, Guildford, UK) for 6 h. Bouin's-fixed tissues were processed and embedded in paraffin wax, and 5-m sections were used for histological analysis as reported previously (22) . Sections of testis and epididymis were stained with hematoxylin and eosin using standard protocols and examined for histological abnormalities.
Serum hormone analysis
Immediately after culling, blood was collected from mice by cardiac puncture. Sera were separated and stored at 20 C until assayed for testosterone and LH as previously published (26, 27) . The within-assay coefficients of variation were all less than 10%.
Determination of deletion of AR exon 2
Evaluation of exon 2 ablation in AR mRNA was based on previously published protocols (22) . Briefly, RNA was isolated from frozen epididymides from control or CEARKO mice using the RNeasy Mini extraction kit (Qiagen, Crawley, UK) according to the manufacturer's instructions. RNA was quantified on a Thermo Scientific NanoDrop 1000 spectrophotometer (Thermo Scientific, San Jose, CA, USA). Random hexamer-primed cDNA was prepared using the Applied Biosystems TaqMan RT kit (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. RT-PCR was performed using BioMix Red Taq polymerase (Bioline, London, UK) on cDNA synthesized from epididymides from control and CEARKO littermates using primers for AR exons 1 and 3 (forward AAGCAGGTAGCTCT-GGGACA; reverse CGTTTCTGCTGGCACATAGA). This resulted in a product of 765 bp if AR exon 2 was present and 613 bp if exon 2 had been ablated by Cre recombinase. A weak central band was also identified; this has previously been confirmed as an artifact (22) .
Immunohistochemistry
Immunohistochemical staining for AR, ER␣, CD45, or smooth muscle actin (SMA) was performed on CEARKO and littermate controls and staining for YFP was performed on FoxG1YFP mice and littermate controls. Sections were deparaffinized and rehydrated, and high-pressure antigen retrieval was performed in citrate buffer for 5 min. For AR, ER␣, CD45, and YFP, nonspecific binding sites were blocked using 3% hydrogen peroxide in methanol to block endogenous peroxidase and normal goat serum (NGS)/TBS/BSA to block nonspecific antibody binding. Sections were incubated overnight at 4 C with the primary antibody for AR (Santa Cruz SC-816 diluted 1 in 200), ER␣ (NovoCastra NCL-ER-6F11, diluted 1 in 500), CD45 (Abcam ab10558 diluted 1 in 50), or GFP/YFP (Abcam ab38689 diluted 1 in 200) in NGS/TBS/BSA. Immunostaining was detected using goat antirabbit biotinylated (BA-1000, Vector Laboratories, Peterborough, UK) diluted 1:500 in NGS/TBS/BSA for AR and CD45 or goat antimouse biotinylated (E0433, Dako, Ely, UK) diluted 1:500 in NGS/TBS/BSA for GFP/YFP and ER␣. All slides were incubated for 60 min with the secondary antibody, then for 30 min with streptavidin-conjugated HRP (SA-5004, Vector Laboratories) diluted 1 in 1000 in TBS, then with diaminobenzidine (SK-4105, Vector Laboratories) as per the manufacturer's instructions. For SMA, automated immunohistochemistry was performed on a Bond-max machine (Leica, UK) using ␣-SMA (Sigma A2547) primary antibody at 1:10,000 concentration and a Polymer Refine Detection kit according to the manufacturer's instructions.
Diaminobenzidine immunostained slides were counterstained with hematoxylin, dehydrated, and mounted with Pertex (Histolab, Gothenburg, Sweden); images were captured using a Provis AX70 microscope (Olympus, Southend-on-Sea, UK) equipped a Axiocam HRc (Zeiss, Welwyn Garden City, UK). To ensure reproducibility of results, representative testes from at least three animals at each age were used, and sections from CEARKO and control littermates were processed in parallel on the same slide on at least two occasions. Appropriate negative controls were included to ensure that any staining observed was specific.
Quantification of AR ablation in the epididymis
AR ablation was quantified in epididymis sections immunostained for AR from three CEARKO animals at d2 and d100. No AR ablation could be seen in the epithelium of control animals, so these were not quantified. Sections were analyzed using Image-Pro Plus 6.2 software with a Stereology 5.0 plug-in (Media Cybernetics UK, Berkshire, UK) with the ϫ63 objective on a Leitz DBRB microscope fitted with a Prior Pro-Scan automatic stage (Prior Scientific Instruments Ltd., Cambridge, UK). The Count (NV) setting was used to count all cells staining either positive or negative for AR in the epithelium of the proximal caput epididymis region (segment II).
Quantification of epithelial cell height in the epididymis
Epithelial cell height was quantified in epididymis sections immunostained for AR from three CEARKO and three control animals at d11, d21, and d100. Sections were analyzed using Image-Pro Plus 6.2 software with a Stereology 5.0 plug-in (Media Cybernetics UK, Berkshire, UK) with the ϫ40 objective on a Leitz DBRB microscope fitted with a Prior Pro-Scan automatic stage (Prior Scientific Instruments Ltd., Cambridge, UK). For each thin-section, epithelial cell height was measured in every fifth cell in each tubule cross-section present in the proximal caput epididymis region (segment II) of the thin-section. In CEARKO mice, epithelial cell height was measured separately for AR-positive and AR-negative cells.
Quantification of epididymal lumen radius
Lumen radius was quantified in epididymis sections from three CEARKO and three control animals at d11, d21, and d100. Sections were analyzed using Image-Pro Plus 6.2 software with a Stereology 5.0 plug-in (Media Cybernetics UK, Berkshire, UK) with the ϫ20 objective on a Leitz DBRB microscope fitted with a Prior Pro-Scan automatic stage (Prior Scientific Instruments Ltd., Cambridge, UK). The 'nucleator' setting was used to measure lumen radius at six points in each epididymal tubule crosssection present in the proximal caput epididymis region (segment II) of the thin-section.
Quantification of seminiferous tubule and tubule lumen radii
Seminiferous tubule and tubule lumen radii were quantified in a thin section taken from the center of the testis of five CEARKO and five control animals at d100. Sections were analyzed using Image-Pro Plus 6.2 software with a Stereology 5.0 plug-in (Media Cybernetics UK, Berkshire, UK) with the ϫ20 objective on a Leitz DBRB microscope fitted with a Prior Pro-Scan automatic stage (Prior Scientific Instruments Ltd., Cambridge, UK). The 'nucleator' setting was used to measure the tubule and lumen radii at six points in 100 individual seminiferous tubule crosssections from each thin section. The mean tubule and lumen radius for each mouse was then calculated.
Evaluation of fertility
To investigate fertility, d100 CEARKO (n ϭ 4) and control (n ϭ 3) males were each housed with an adult wild-type female for 4 d and the presence of a postcopulatory vaginal plug was recorded. This process was repeated with three subsequent wildtype mice per male. Female mice were monitored for 25 days for litters to be born. Matings were scored as successful if one or more pups were born.
Statistical analysis
Data were analyzed using GraphPad Prism (version 5; GraphPad Software Inc., San Diego, CA, USA) using a twotailed unpaired t test (tissue weight, cell height and lumen radius data) or a 2 test (fertility testing data). Values are expressed as means Ϯ SEM.
Results
Characterization of FoxG1-Cre mice
FoxG1-Cre stud males were mated to females carrying a Cre Recombinase inducible YFP reporter gene (25) to demonstrate Cre Recombinase functional expression (i.e., where Cre Recombinase has functioned YFP will be expressed). Immunohistochemistry for YFP in the epididymis of d100 FoxG1YFP mice revealed that expression of YFP could be detected in the epididymal epithelium ( Fig.  1A ). This expression was mosaic ( Fig. 1B , arrows) and was not detected in stromal cells ( Fig. 1B, asterisk) , although background nonspecific staining was noted. To confirm that Cre Recombinase expression alone did not induce a reproductive phenotype, reproductive tissues were examined from adult males carrying the FoxG1-Cre transgene but no floxed AR. Despite the loss of one allele of FoxG1 resulting from introduction of the Cre Recombinase gene into the locus, all FoxG1-Cre males were fertile and dis-played no reproductive phenotype when examined postmortem (data not shown).
AR ablation in CEARKO epididymides
To confirm functional expression of Cre Recombinase, deletion of exon 2 of AR in epididymides from CEARKO mice was assayed at d2 by RT-PCR (Fig. 1C ). In control epididymides only full-length AR was detected; both fulllength and KO variants of AR could be detected in CEARKO epididymides although AR only appeared to have been ablated from a proportion of cells ( Fig 1C, arrow) . AR immunostaining and quantification revealed that AR protein was not expressed in 37% of the principal epithelial cells of the proximal caput epididymis at d2 and 67% at d100 ( Fig. 1D ). Ablation of AR was limited to principal cells whereas basal epithelial cells were all positive for AR in CEARKO mice, as in controls. Small foci of AR ablation were occasionally noted in the remainder of the epididymis in CEARKO, but these were too irregular and few to merit quantification (data not shown). All epididymal epithelial cells were immunopositive for AR in controls ( Fig. 1D ).
Gross reproductive tract phenotype of CEARKO mice
Anogenital distance and weights of the seminal vesicles, penis, and prostate did not differ significantly in CEARKO males compared with controls at d11, d16, d21, d35, and d100 (P Ͼ 0.05, n Ն 5 for each group and time point, data not shown). CEARKO epididymides were visibly smaller compared with controls when examined at d100 ( Fig. 2A) ; quantification revealed a significant reduction in epididymal weight in CEARKO mice at both d21 and d100, compared with age-matched control littermates (Fig. 2B ). Serum LH (data not shown) and testosterone ( Fig. 2C) concentrations were not significantly different in CEARKO males compared with controls (P Ͼ 0.05) when examined at either d21 or d100. Histological examination, supported by immunostaining for ER␣ on longitudinal sections through the epididymis of CEARKO and control animals revealed that the initial segment (IS) was absent from d100 CEARKO epididymides ( Fig. 2d, e ).
CEARKO males fail to develop an IS
Control and CEARKO caput epididymides were examined at d11, d21, and d100 to determine whether the IS failed to develop or developed and later regressed. At d11 the proximal caput epididymal epithelium in the CEARKO appeared morphologically similar to that in controls ( Fig. 3A) . Mosaic loss of epithelial AR was already apparent in the d11 CEARKO ( Fig. 3A, arrowhead) . At d21, differentiation of the caput epididymal epithelium was observed in controls; evidence of this includes the development of a visibly distinguishable IS precursor ( Fig. 3A , 'I'), characterized by increasing epithelial cell height and lumen diameter. The IS precursor was not obvious in the CEARKO at d21 and the AR-negative cells in the proximal caput epithelium did not display an increase in height ( Fig 3A, arrowhead) . At d100, control animals displayed a well-developed IS characterized by tall pseudo-stratified columnar epithelia and large tubule lumen ( Fig. 3A , 'I'). Conversely, epithelial cells in the CEARKO segment immediately distal to the efferent ducts resembled those found in segment II, the proximal caput of the control (Fig. 3A , 'II'); as a result, the single lobe of efferent ducts within the epididymal tunica of CEARKO mice connected directly to segment II, the proximal caput ( Fig. 2E ).
AR ablation in the proximal caput epithelium results in impaired epithelial development and function
On histological examination, AR-positive epithelial cells in the CEARKO caput epididymis were visibly increased in height compared with AR-negative epithelial cells at d11, d21 and d100 (Fig. 3B ). This was confirmed to be significantly different by quantification of cell heights (P Յ 0.005) ( Fig. 3C ). AR-positive epithelial cells in CEARKO mice did not differ significantly in height from the AR-positive epithelial cells in control epididymides (Fig. 3C ). Upon histological examination, the average lumen radius in the proximal caput region in d100 CEARKO mice appeared smaller than those of the comparable segment II region in d100 control mice (Fig. 3B, asterisks) . Quantification revealed that at d11, average epididymal lumen radius in segment II of CEARKO mice was similar to controls, but at d21 and d100 the CEARKO lumen radius was significantly smaller than controls (P Յ 0.001) (Fig. 3D) . Scale bar, 1 mm. B, d21 and d100 but not d11 CEARKO epididymides are significantly reduced in weight compared with controls. Examination of epididymidal weight in the SCARKO mouse model, which exhibits spermatogenic arrest at meiosis and consequently lack sperm in their epididymides (18) suggested that the reduction in epididymal weight at d100 was unlikely to be primarily attributable to absence of spermatozoa. (*, P Յ 0.05; ***, P Յ 0.001). Values are means Ϯ SEM, n ϭ 5-10 mice for each group. C, Average serum testosterone concentrations in CEARKO mice were not significantly different to controls when tested at d21 and d100 (P Ͼ 0.05). D, CEARKO epididymides lack the distinct IS seen in controls. Scale bar, 1 mm. E, Immunostaining for ER␣ which is expressed in the efferent ducts (ED) and segments II and III of the caput epididymis, but absent from segment I in control animals, also shows the absence of the IS, with continuous ER␣ϩ tubules forming the junction between the ED and epididymis in CEARKO mice. Scale bar, 500 m for main images, and 50 m for high magnification insets.
AR ablation in the proximal caput epithelium results in an altered smooth muscle cell layer At d11, SMA immunostaining was similar in control and CEARKO epididymides, appearing as a strongly staining ring around the tubules (Fig. 4, arrows) . However, at d100 the smooth muscle layer of the CEARKO epididymis was disorganized with evidence of disruption at specific foci (Fig. 4, arrowhead) .
CEARKO males develop obstructive azoospermia
Neither control nor CEARKO efferent duct epithelia displayed areas of ablation of AR at any age observed. At   FIG. 3 . Development, morphology, and function of the proximal caput epididymis epithelium is altered in CEARKO mice. A, d11 control caput epididymal epithelium is low columnar and AR-positive (arrow). d11 CEARKO caput epididymal epithelium appears grossly comparable to that in controls but with areas of epithelial AR ablation (arrowheads). d21 control caput epididymal epithelium has begun to increase in height where the IS (I) will develop, and is distinguishable from the proximal caput (II), conversely epididymal epithelium of the d21 CEARKO remains low columnar. d100 control proximal epididymis is segmented with epithelium characteristic of the tall pseudo-stratified columnar epithelium of the IS (I) next to the lower columnar epithelium of the proximal caput (II). d100 CEARKO proximal epididymis is disordered with no epithelial characteristics of the IS. AR-negative areas (arrowhead) of d100 CEARKO epithelium are shorter, with more columnar cells (arrowhead), compared with AR-positive epithelial cells which are taller (arrow) and visibly comparable to segment II rather than segment I of the control. Scale bar, 50 m. B, The irregular appearance of the epithelium in d100 CEARKO epididymides is attributable to a visible reduction in height of AR-negative compared with AR-positive areas. Basal cells in the proximal epididymal epithelium of the CEARKO are AR-positive (arrows). The proximal epididymal lumen in the CEARKO is irregularly shaped compared with the circular lumen of controls (asterisks). Stereocilia are present on the apical surface of AR-positive epithelial cells in d100 controls and CEARKOs (arrowheads) but are absent in AR-negative epithelial cells of the CEARKO. Scale bar, 20 m. C, The height of AR-negative epithelial cells is significantly smaller (***, P Յ 0.001; **, P Յ 0.005) than that of AR-positive epithelial cells within CEARKO proximal caput epididymis at d11, d21, and d100. There was no significant difference between the AR-positive cells of the proximal caput epididymis in controls and CEARKOs (P Ͼ 0.05) at any age examined. Values are means Ϯ SEM, n ϭ 3 mice for each group. D, At d11 the caput epididymal lumen radius of CEARKO mice is not significantly different from that of control mice (P Ͼ 0.05). At d21 and d100 proximal caput epididymal lumen of CEARKO mice is significantly smaller than that of control mice (***, P Յ 0.001). Values are means Ϯ SEM, n ϭ 3 mice for each group.
Endocrinology, February 2011, 152(2):718 -729 endo.endojournals.org d11, the efferent ducts of CEARKO mice were indistinguishable from those in controls (Fig. 5A ). In both cases, the efferent ducts appeared patent, with cellular debris within the lumen (Fig. 5A, arrows) . At d21, an increase in the amount of cellular debris and proteinaceous exudate was observed in the efferent ducts of CEARKO mice compared with that in controls (Fig. 5A, asterisk) . At d100, clusters of spermatozoa were evident in the efferent ducts of the CEARKO and these appeared to have formed a physical 'block,' preventing spermatozoa from passing through the lumen (Fig. 5A, cross) . Conversely, control efferent duct lumens did not contain obvious groups of cells/spermatozoa at d21 or d100 (Fig. 5A, arrowheads) . Cilia present on the apical surface of some cells in the control efferent ducts were also noted in the CEARKO (Fig. 5B, arrows) .
Inflammation and phagocytosis of the luminal sperm is noted in the d100 CEARKO efferent ducts
The occasional cell was CD45ϩ in the efferent duct stroma of d100 controls. Conversely, the efferent ducts of d100 CEARKO mice displayed widespread CD45 immunostaining in stromal, epithelial, and luminal compartments of the efferent ducts (Fig. 5C ). Phagocytosis of stagnant sperm was apparent in the epithelia of some efferent duct cross-sections, as shown by dense accumulations of the characteristic 'hooked' spermatozoa heads inside CD45ϩ cells in the epithelium (Fig. 5C, arrow) .
CEARKO males are infertile
Spermatozoa are stored in the cauda epididymis before entering the vas deferens during ejaculation. In d100 control mice, densely-packed spermatozoa were present in the lumen of the cauda epididymis (Fig. 6A, crosses) . In d100 CEARKO mice proteinaceous material could be widely detected (Fig. 6A, asterisks) . A few spermatozoa could be observed in the cauda epididymis (Fig 6B, arrow) . CEARKO males sired significantly fewer litters, (with just a single mating proving successful, representing 6% of total matings undertaken) than controls did (83% of matings; 2 P Յ 0.001). Furthermore, the sole CEARKO male that did produce a litter failed to produce litters in three further matings. However, postcopulatory vaginal plugs were evident in after CEARKO matings suggesting normal mating behavior and ejaculation had occurred.
CEARKO mice develop a secondary testicular phenotype
Average testis weight of CEARKO mice was significantly reduced at d21 and d100, but not at d11, compared with controls ( Fig. 7A ). Stereological measurements revealed no significant difference in either tubule diameter or lumen diameter at d21 (data not shown), however, at d100 average tubule radius was significantly reduced, while there was a significant increase in lumen radius ( Fig  7B) consistent with atrophy of the seminiferous epithelium at specific foci in the CEARKO testis (Fig. 7C, arrow) . In other areas of the testis, spermatogenesis was unaffected (Fig. 7C, arrowheads) . At d100, accumulation of spermatozoa resulted in gross distension of the proximal efferent ducts and rete testis in the CEARKO (Fig. 7d, asterisks ).
Discussion
To establish whether cell-specific expression of AR in the caput epididymal epithelium was essential for formation and function of the epididymis, AR was ablated from a proportion of proximal caput epididymal epithelial cells through conditional gene-targeting. In the resulting CEARKO mice, the IS of the epididymis failed to develop. Furthermore, the cells in the remaining caput epithelium in which AR was ablated, failed to mature fully leading to a reduction in luminal diameter and impaired epithelial cell function. These abnormalities resulted in stasis of spermatozoa in the efferent ducts of CEARKO mice, which ultimately developed into a physical obstruction that resulted in fluid back-pressure, gross distension of the rete testis, and severe disruption to testicular architecture and spermatogenesis.
The epididymis in CEARKO mice is grossly and histologically indistinguishable from that of controls at d2, despite AR ablation in 37% of caput epithelial cells. CEARKO anogenital distance, an indicator of normal prenatal androgen exposure in the male, is not significantly different from control males suggesting that the reproduc- tive system has been exposed to adequate androgen concentrations for masculinization (28) . Normal epididymal development is known to be under the control of androgens, as WD-derived tissues are absent at birth in genetic models of ablation of AR function (7, 8) and the epididymis fails to coil in male rats treated prenatally with the AR antagonist flutamide (9) . However, prenatal androgen action is mediated by stromal AR in the WD, and epithelial AR is not detected until after the WD has stabilized and begun to coil. These results are consistent with our observa-tion that neonatal development of the CEARKO epididymis appears normal. Conversely, early postnatal maturation of the epididymis is compromised in CEARKO mice. At d11, control and CEARKO epididymides appear grossly similar with no significant difference in weight, but histological abnormalities were already evident at this age. There is a significant difference in epithelial cell height between AR-positive and AR-negative cells in CEARKO epididymides at d11. Previously published literature suggested that the epididymal epithelium in mice exists in an undifferentiated state from d7 to d14 (29) , at which point a 'precursor' epithelium arises. However our data suggest that the epithelium is already responsive to androgens at d11 and possibly even earlier, as AR-ablated and AR-positive cells at this age display different morphology.
By adulthood, gross abnormalities can be identified in CEARKO epididymides. At d100, CEARKO mice lack the IS (segment I) of the epididymis, so the proximal caput epididymis (segment II) is located immediately distal to the efferent ducts. Analysis of epididymal histology at d11, d21, and d100 demonstrated that the IS was not absent because it had regressed, but rather that it had completely failed to develop in CEARKO mice. By d21, the IS precursor is obvious in control mice, characterized by increasing epithelial cell height and lumen diameter. However, in the d21 CEARKO epididymis, epithelial cells lacking AR failed to increase in height or develop stereocilia in the principal cells of the proximal caput, maintaining a similar morphology to that of the pre-differentiated epithelium at d11. Previously published studies have shown that IS development is under the control of a number of factors including circulating androgens, the product of the gene c-ros and testicular lumicrine factors (29) . At day 16, the epithelium of segment I (IS) is reported to become visually distinct from the remaining caput epithelium, while segment II (proximal caput) and III (distal caput) of the epididymis appear differentiated by d21. Acute withdrawal FIG. 5. CEARKO mice develop a block of spermatozoa and cellular debris in their efferent ducts. Efferent duct inflammation and phagocytosis of spermatozoa heads is noted. d11 control and CEARKO efferent ducts are visibly similar, with cellular debris present in the lumens of both (arrows). Efferent ducts of d21 controls are patent and empty (arrowhead), whereas d21 CEARKO efferent ducts are beginning to accumulate proteinaceous and cellular debris (asterisk). d100 control efferent ducts have empty, patent lumens (arrowhead), unlike d100 CEARKO efferent ducts which are distended and contain static spermatozoa and cellular debris in their lumens (cross). Neither control nor CEARKO efferent duct epithelia displayed areas of ablation of AR at any age observed. Scale bars, 100 m. B, Cilia are present on the apical surfaces of some cells in the control efferent ducts, and can also be seen in the CEARKO (arrows). C, Specific staining for CD45 can be seen in the occasional stromal cell in d100 control efferent ducts (solid arrowhead) but can be seen in stromal (solid arrowhead), epithelial (outline arrowhead), and luminal (cross) cells in the d100 CEARKO efferent ducts. Higher magnification image shows phagocytosis of spermatozoa heads by the CEARKO efferent duct epithelium (arrow). Scale bars, 20 m (B and C).
Endocrinology, February 2011, 152(2):718 -729 endo.endojournals.org of androgens after orchidectomy results in regression of segment I and dedifferentiation of segments II and III to a 'precursor' state, suggesting that continuous androgen exposure is required to maintain a differentiated epididymal epithelium (16) . Consistent with this, we conclude that in the absence of epithelial AR, the proximal epithelium of the caput is unable to undergo correct terminal differentiation, resulting in complete failure of development of the IS. Because lumicrine factors from the testis are also thought to be needed for maintenance of the IS (30), the presence of an obstruction in the efferent ducts at later ages likely compounds this phenotype by preventing testicular lumicrine factors from passing into the epididymis. This requires further investigation. AR-negative epithelial cells within the remainder of the CEARKO caput epididymis also fail to mature. This resulted in the persistence of areas of undifferentiated epithelium with reduced cell height compared with the ARpositive epithelial cells, and a decrease in lumen size at d11, d21, and d100 in the CEARKO caput. The striking difference in both epithelial cell height and morphology between AR-positive and AR-negative cells suggests that the impact of AR-dependent signaling on epithelial cells is predominantly autocrine, not paracrine. Despite lumen diameter differences between the CEARKO and control, AR-positive CEARKO epithelial cells in the remaining proximal caput of the CEARKO did not significantly differ in height compared with cells in segment II of the ubiq-uitously AR-positive control epididymal epithelium. This suggests that AR-positive caput epithelium in the CEARKO is comparable to segment II in the control. The IS is believed to develop from a different anlage to the rest of the epididymis, namely the mesonephric tubules, while the remaining caput develops from the WD (4). This divergent origin may explain the differential response of the two epididymal regions to AR ablation in CEARKO mice, with epithelial AR signaling a fundamental requirement for development of the IS but not the caput; epithelial AR is however important in regulating epithelial cell function in the remainder of the caput.
Previous models of epididymal androgen deprivation by orchidectomy reported apoptosis in the epididymal epithelium (14, 15) . In contrast, the epithelium of CEARKO mice did not display the characteristic histological signs of apoptosis. It is possible that epithelial cells in CEARKO epididymides do not undergo apoptosis because AR has been ablated from birth and the epithelia never develop correctly, whereas in previous studies androgen withdrawal took place after the differentiation of the epididymal epithelium (14, 15) . This suggests that apoptosis either occurs in epithelial cells that have developed under the influence of androgens as a direct response to acute androgen withdrawal or that it is a secondary response to a reduction in androgens in the stromal compartment resulting in a disruption in mesenchymal-epithelial signaling. This requires further investigation.
The failure of the proximal epithelium of the CEARKO epididymis to differentiate correctly results in an obstruction developing in the efferent ducts. From d21, CEARKO efferent ducts begin to accumulate proteinaceous and cellular debris that would normally pass through the epididymis and be phagocytosed in the cauda in controls. When spermiation occurs at around d35 in the mouse, some CEARKO mice had spermatozoa in the epididymis despite having developed these histological changes in the efferent ducts. However, by d100 all CEARKO epididymides examined were near azoospermic with spermatozoa stasis in the efferent ducts, suggesting that the phenotype was progressively degenerative. Previous reports suggest that the absence of an IS per se does not cause obstructive azoospermia. For example although the c-ros Ϫ/Ϫ mutant mouse fails to develop an IS, the spermatozoa progress straight from the efferent ducts to the distal caput of the epididymis (31) . Although c-ros Ϫ/Ϫ spermatozoa reach the cauda epididymis, they have angulated tails and swollen heads due to problems with volume regulation (32) . However, the remaining caput epithelium in c-ros Ϫ/Ϫ mice developed and differentiated normally under the influence of androgens, suggesting obstructive azoospermia in CEARKO mice is likely to result from persistence of an incorrectly differentiated epididymal epithelium rather than absence of an IS. A further morphological characteristic that may have contributed to stasis of spermatozoa in the CEARKO efferent ducts was the visibly smaller and more irregular lumen diameter of the CEARKO caput epididymis. This could cause a 'bottleneck' point for spermatozoa and testicular fluids, slowing down their transit and resulting in accumulation upstream in the efferent ducts. This could result in a self-perpetuating stasis, leading to changes in the composition of testicular fluid and spermatozoa in the efferent ducts and further blockage. This view is supported both through our own observations and other published models of obstructive azoospermia. For example, mice with a knock-out of LGR4/GPR48 fail to undergo proper epididymal convolution and exhibit persistence of an undifferentiated epithelium in the epididymis (33) . Other reported models of obstructive azoospermia implicate epithelial dysregulation of the efferent ducts and caput epididymis due to abnormal transepithelial fluid transport (34) . One such example is the phenotype of mice with a knock-out of GPR64, an orphan GPCR located on the apical membrane of efferent ducts and stereocilia of epididymal caput principal cells (35) . GPR64 knock-out mice display a similar stasis of spermatozoa in their efferent ducts, and incorrect fluid transport by the efferent ducts and epididymis is implicated (36) . Androgens are known to control the height of epididymal stereocilia (37) and the AR-ablated immature epithelium of the proximal epididymis of CEARKO mice lacked stereocilia which are characteristic of mature epididymal epithelial cells of this region. It is therefore probable that the localization of many important fluid and solute transport proteins such as GPR64 are compromised in the CEARKO. Identification of specific factors requires further investigation.
To establish whether AR ablation in the caput epididymal epithelium impacts upon the surrounding stroma, ␣-SMA expression (9) was investigated as a marker of epididymal smooth muscle cells. At d11 the staining for SMA in CEARKO caput epididymides appeared similar to that in controls. However, at d100 the smooth muscle layer of the CEARKO epididymis was disorganized with evidence of disruption at specific foci, suggesting that smooth muscle function may be compromised in the CEARKO epididymis and that this could be compounding the problems with spermatozoa transport. This observation is likely to be an effect rather than a cause of the impaired development of the epithelium, because there is no observable difference in SMA staining in CEARKO mice epididymides compared with controls at d11. Reciprocal homeostatic interaction between epithelium and smooth muscle in the adult pros-FIG. 7. CEARKO mice display a significant reduction in testis weight from d21, and disruption to the seminiferous epithelium coincident with the physical block in the efferent ducts. A, CEARKO testes are significantly reduced in weight compared with controls at d21 and d100 (both **, P Յ 0.005) but not at d11 (P Ͼ 0.05). Values are means Ϯ SEM, n ϭ 5-20 mice for each group. B, Average seminiferous tubule radius is significantly smaller in the d100 CEARKO than the control (*, P Յ 0.05), whereas average seminiferous tubule lumen radius in the d100 CEARKO is significantly greater than the control (**, P Յ 0.005). C, d100 CEARKO testes display fluid-induced distension of seminiferous tubules (asterisk) and sloughing of the seminiferous epithelium (arrow), however some tubules still appear to undergo normal spermatogenesis comparable to controls (arrowheads). D, The rete testis (asterisk) of d100 CEARKO mice is distended with fluid, mature spermatozoa, and pieces of sloughed seminiferous epithelium when compared with the rete of a d100 control. Scale bars, 200 m (C and D).
Endocrinology, February 2011, 152(2):718 -729 endo.endojournals.org tate has been previously demonstrated (38) , so it is probable that disruption of epithelium in the epididymis also causes dysfunction in the surrounding smooth muscle layer; this requires further investigation.
Previous studies have noted that the physical blockage of the efferent ducts by sperm stasis results in inflammation and phagocytosis by the ductal epithelium (39, 40) . This is also apparent in the CEARKO model at d100, with more cells immunostaining CD45ϩ compared with controls. Of particular interest is the morphology and locations of the CD45ϩ cells, noted in the stroma, dispersed throughout the efferent duct epithelium and also interspersed with spermatozoa in the lumen of efferent duct cross-sections in the conus region of the efferent ducts. Foci of dense spermatozoa heads can also be noted inside epithelial cells that stain CD45ϩ, showing that they are being phagocytosed by immune cells within the ductal epithelium. The presence of similar CD45ϩ cell syncytia has been noted in efferent duct block phenotype of the LGR4 knock-out mouse (33) . The development of a physical block in the efferent ducts induced both gross and histological changes in the testis of the CEARKO at later ages. Average CEARKO testis weight was significantly smaller than controls at both d21 and d100. Stereological quantification revealed a reduction in tubule diameter with an increase in lumen diameter at d100 consistent with atrophy of the seminiferous tubules and sloughing of the seminiferous epithelium in CEARKO testes. This latestage testicular phenotype is similar to that found after acute efferent duct blockage (40) and suggests that the degeneration seen in the testis is a consequence of the efferent duct block. However, the transient increase in testis weight predicted from this model was not observed in the CEARKO model. This may be due to the observed epithelial phagocytosis relieving fluid pressure and accumulation of sperm to some extent. Further to this, the CEARKO model represents a 'chronic treatment' with a progressively worsening phenotype in a developing system rather than an 'acute treatment' whose impacts are widespread and immediate (e.g., efferent duct ligation or chemical insult).
In conclusion, the CEARKO model of conditional AR ablation in the proximal caput epithelium of the epididymis advances understanding of the role of epithelial AR in WD-derived tissues, demonstrating that epithelial cell AR is a fundamental requirement for postnatal development of the IS of the epididymis. We have also shown that ablation of AR in epithelial cells of the remainder of the caput epididymis leads to failure of epithelial cell maturation, and a reduction in lumen diameter which together contribute to stasis of spermatozoa in the efferent duct, targeting of AR in the caput epithelium with a RNase 10-Cre line produced a similar phenotype in a recent independent study (41) . These studies provide a novel mouse model of obstructive azoospermia which will aid our understanding of the causes of male infertility, and the identification of novel therapeutic targets for development of male contraceptives.
